Nakamoto Yuji, Chin Bennett B, Kraitchman Dara L, Lawler Leo P, Marshall Laura T, Wahl Richard L
Department of Radiology, Division of Nuclear Medicine, Johns Hopkins University Hospital, 601 N Caroline St, Rm 3223, Baltimore, MD 21287-0817, USA.
Radiology. 2003 Jun;227(3):817-24. doi: 10.1148/radiol.2273020299.
To investigate the effects of intravenous contrast agents on quantitative values obtained with a combined positron emission tomographic (PET) and computed tomographic (CT) scanner by using several phantoms and a dog.
Fluorine 18 fluorodeoxyglucose (FDG) was mixed with different concentrations of contrast agent with the same syringe (phantom 1), and the phantom was scanned. After image reconstruction with various attenuation maps, radioactivity concentrations were compared. Then, FDG solutions with (phantom 2) or surrounded by (phantom 3) various concentrations of contrast agent were scanned repeatedly, and radioactivity concentration was compared. Finally, PET and CT with and without contrast agent were performed in a dog. PET images were reconstructed by using different attenuation maps, and radioactivity concentrations were compared. The radioactivity concentration on germanium 68 (68Ge)-based corrected images was regarded as standard, and percentage bias, defined as difference divided by measured activity of 68Ge-based corrected images, was assessed. The relationship between the concentration of contrast agent and the percentage bias was assessed with the Pearson coefficient r, and the significance of correlations was evaluated with the Fisher z test.
All phantom studies demonstrated that presence of a contrast agent resulted in overestimation of emission data. CT numbers showed a strong positive correlation with the percentage bias in phantoms 2 (r = 0.999) and 3 (r = 0.987); the maximum percentage bias at 1,360 HU reached approximately 45%. These effects were independent of FDG concentration. In a canine model, presence of a contrast agent also increased emission activity, but the percentage bias was less than 15% in the liver and smaller in all other organs except the kidney (26%).
High concentrations of a contrast agent caused considerable overestimation of apparent tracer activity in phantom studies; however, the emission bias was relatively modest in vivo, except in areas with very high contrast agent concentrations.
通过使用多个体模和一只狗,研究静脉注射造影剂对正电子发射断层扫描(PET)和计算机断层扫描(CT)联合扫描仪获得的定量值的影响。
将氟代脱氧葡萄糖(FDG)与不同浓度的造影剂在同一注射器中混合(体模1),然后对体模进行扫描。使用各种衰减图进行图像重建后,比较放射性浓度。接着,对含有(体模2)或被不同浓度造影剂包围(体模3)的FDG溶液进行多次扫描,并比较放射性浓度。最后,在一只狗身上进行有无造影剂的PET和CT检查。使用不同的衰减图重建PET图像,并比较放射性浓度。将基于锗68(68Ge)校正图像上的放射性浓度视为标准,评估百分比偏差,其定义为差值除以基于68Ge校正图像的测量活性。用Pearson系数r评估造影剂浓度与百分比偏差之间的关系,并用Fisher z检验评估相关性的显著性。
所有体模研究均表明,造影剂的存在导致发射数据高估。CT值与体模2(r = 0.999)和体模3(r = 0.987)中的百分比偏差呈强正相关;在1360 HU时最大百分比偏差达到约45%。这些影响与FDG浓度无关。在犬类模型中,造影剂的存在也增加了发射活性,但肝脏中的百分比偏差小于15%,除肾脏外(26%)所有其他器官中的偏差更小。
在体模研究中,高浓度造影剂导致明显的示踪剂活性高估;然而,除了造影剂浓度非常高的区域外,体内发射偏差相对较小。